A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

Status:
RECRUITING

Trial end date:
2027-05-01

Target enrollment:

Participant gender:

This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.

PHASE1

Generate Biomedicines